Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACXP Acurx Pharmaceuticals, LLC*

休市中 12-12 16:00:00 EST

4.07

-0.04

-0.97%

盘后4.05

-0.02-0.49%

18:38 EST

最高4.26	最低4.05	成交量3.36万
今开4.13	昨收4.11	日振幅4.99%
总市值847.09万	流通市值735.94万	总股本208.13万
成交额13.84万	换手率1.86%	流通股本180.82万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":4.07,"timestamp":1765573200000,"preClose":4.11,"halted":0,"volume":33585,"hourTrading":{"tag":"盘后","latestPrice":4.05,"preClose":4.07,"latestTime":"18:38 EST","volume":685,"amount":2783.008,"timestamp":1765582708944},"delay":0,"floatShares":1808200,"shares":2081300,"eps":-10.366422,"marketStatus":"休市中","change":-0.04,"latestTime":"12-12 16:00:00 EST","open":4.13,"high":4.255,"low":4.05,"amount":138439.75453500001,"amplitude":0.049878,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.366422,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":4.11,"preHourTrading":{"tag":"盘前","latestPrice":4.18,"preClose":4.11,"latestTime":"09:29 EST","volume":183,"amount":763.4705832000001,"timestamp":1765549770149},"postHourTrading":{"tag":"盘后","latestPrice":4.05,"preClose":4.07,"latestTime":"18:38 EST","volume":685,"amount":2783.008,"timestamp":1765582708944},"volumeRatio":0.17879912922451424,"impliedVol":1.1448,"impliedVolPercentile":0.761},"requestUrl":"/m/hq/s/ACXP/wiki","defaultTab":"wiki","newsList":[{"id":"1183883275","title":"Acurx Pharmaceuticals将在2025年11月12日电话会议上讨论2025年第三季度财务结果并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1183883275","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183883275?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:02","pubTimestamp":1761566559,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals将在2025年11月12日的电话会议上讨论2025年第三季度的财务结果，并提供业务更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","ACXP","BK4539"],"gpt_icon":0},{"id":"1115056977","title":"Acurx Pharmaceuticals宣布欧洲药品管理局对伊贝扎波司他治疗儿童艰难梭菌感染的儿科研究计划给予积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056977","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115056977?lang=zh_cn&edition=full","pubTime":"2025-09-30 19:33","pubTimestamp":1759231998,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals宣布，欧洲药品管理局(EMA)对该公司伊贝扎波司他用于治疗儿童艰难梭菌感染的儿科研究计划给予了积极意见。这一积极意见为该药物在儿科患者中的进一步开发和应用奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0},{"id":"2568226163","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘急速拉升7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568226163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568226163?lang=zh_cn&edition=full","pubTime":"2025-09-19 21:33","pubTimestamp":1758288793,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日21时33分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速上涨7.14%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509192133149538bd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509192133149538bd71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4139","BK4539"],"gpt_icon":0},{"id":"2567612016","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速跳水5.10%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567612016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567612016?lang=zh_cn&edition=full","pubTime":"2025-09-16 00:30","pubTimestamp":1757953855,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日00时30分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.10%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509160030559793fa2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509160030559793fa2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4539","BK4139"],"gpt_icon":0},{"id":"1137767409","title":"Acurx Pharmaceuticals重新符合纳斯达克最低收盘价及股东权益规定","url":"https://stock-news.laohu8.com/highlight/detail?id=1137767409","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137767409?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:04","pubTimestamp":1756897472,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals重新符合纳斯达克最低收盘价及股东权益规定","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4539","BK4139","ACXP"],"gpt_icon":0},{"id":"2564335121","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘急速下挫6.28%报4.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564335121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564335121?lang=zh_cn&edition=full","pubTime":"2025-09-03 02:22","pubTimestamp":1756837332,"startTime":"0","endTime":"0","summary":"北京时间2025年09月03日02时22分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.28%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903022212a70c0e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903022212a70c0e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","BK4139","ACXP"],"gpt_icon":0},{"id":"2557988505","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557988505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557988505?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:06","pubTimestamp":1754586367,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时06分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.93%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808010607a47b7017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808010607a47b7017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","ACXP","BK4539"],"gpt_icon":0},{"id":"2556387509","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556387509?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:44","pubTimestamp":1754315049,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时44分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.50%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804214409a4749512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804214409a4749512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2556817679","title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌5.06%报0.310美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817679?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:32","pubTimestamp":1754062356,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时32分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.06%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801233236a6ce16a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801233236a6ce16a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4563","ACXP"],"gpt_icon":0},{"id":"2555028686","title":"Acurx Pharmaceuticals, Inc.股价重挫20.42% 市值跌12.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555028686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555028686?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:52","pubTimestamp":1753887124,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日22时52分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水20.42%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730225204a46bcfbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2555052286","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.88%报0.384美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052286?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:54","pubTimestamp":1753797280,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时54分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.88%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544094c1af00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544094c1af00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2552847644","title":"Acurx Pharmaceuticals, Inc.盘中异动 急速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552847644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552847644?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:32","pubTimestamp":1752759129,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时32分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.16%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213209a6aff654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717213209a6aff654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2551191113","title":"Acurx Pharmaceuticals, Inc.7月15日成交额为37.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551191113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551191113?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:15","pubTimestamp":1752628533,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，Acurx Pharmaceuticals, Inc.成交额为37.40万美元，成交额较昨日增加52.55%，当日成交量为85.11万股。Acurx Pharmaceuticals, Inc.于2025年7月15日跌4.91%，报0.434美元，该股过去5个交易日跌11.33%，年初至今跌46.73%，过去60日涨12.62%。该公司的方法是开发具有革兰氏阳性选择性谱的候选抗生素。该公司的部门包括开发临床和临床前候选产品，以开发公司的专有新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716091549a6ac2c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2551133783","title":"Acurx Pharmaceuticals, Inc.盘中异动 急速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551133783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551133783?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:55","pubTimestamp":1752519353,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日02时55分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.12%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715025553a6a95558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715025553a6a95558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ACXP","BK4139","BK4563"],"gpt_icon":0},{"id":"2550560812","title":"Acurx Pharmaceuticals, Inc.7月10日成交额为42.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550560812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550560812?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:15","pubTimestamp":1752196534,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Acurx Pharmaceuticals, Inc.成交额为42.32万美元，成交额较昨日减少53.61%，当日成交量为84.49万股。Acurx Pharmaceuticals, Inc.于2025年7月10日跌0.2%，报0.499美元，该股过去5个交易日涨2.46%，年初至今跌38.7%，过去60日涨40.96%。该公司的方法是开发具有革兰氏阳性选择性谱的候选抗生素。该公司的部门包括开发临床和临床前候选产品，以开发公司的专有新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091550a6a28e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091550a6a28e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0},{"id":"2550655847","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大涨5.20%报0.514美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550655847?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:04","pubTimestamp":1752069848,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时04分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.20%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220408979fbd5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709220408979fbd5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2549552868","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549552868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549552868?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:43","pubTimestamp":1751982182,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时43分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.64%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214303953ae763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708214303953ae763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2549530738","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大涨5.81%报0.510美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530738?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:33","pubTimestamp":1751895205,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时33分，Acurx Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.81%。截至发稿，该股报0.510美元/股，成交量8.6338万股，换手率0.37%，振幅2.07%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213325979d17d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213325979d17d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2548338848","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548338848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548338848?lang=zh_cn&edition=full","pubTime":"2025-07-03 22:10","pubTimestamp":1751551837,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时10分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.73%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发一类新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032210379798b433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032210379798b433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2548910834","title":"Acurx Pharmaceuticals, Inc.7月1日成交额为35.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548910834","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548910834?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:15","pubTimestamp":1751418931,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Acurx Pharmaceuticals, Inc.成交额为35.90万美元，成交额较昨日减少69.42%，当日成交量为70.60万股。Acurx Pharmaceuticals, Inc.于2025年7月1日跌3.88%，报0.491美元，该股过去5个交易日跌21.94%，年初至今跌39.68%，过去60日涨48.79%。该公司的方法是开发具有革兰氏阳性选择性谱的候选抗生素。该公司的部门包括开发临床和临床前候选产品，以开发公司的专有新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702091544a4c9ec36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702091544a4c9ec36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4139","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acurxpharma.com","stockEarnings":[{"period":"1week","weight":0.2679},{"period":"1month","weight":-0.1827},{"period":"3month","weight":-0.0557},{"period":"6month","weight":-0.3328},{"period":"1year","weight":-0.7706},{"period":"ytd","weight":-0.75}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立，于2018年2月开始运营。该公司是一家后期生物制药公司，专注于开发用于难治疗细菌感染的新型小分子抗生素，用于治疗被世界卫生组织列为优先病原体的细菌引起的感染（“WHO”），美国疾病控制与预防中心（“CDC”）和美国食品和药物管理局（“FDA”）。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性（“AMR”）危机的病原体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.095374},{"month":2,"riseRate":0,"avgChangeRate":-0.089244},{"month":3,"riseRate":0.25,"avgChangeRate":-0.162505},{"month":4,"riseRate":0.5,"avgChangeRate":0.00047},{"month":5,"riseRate":0.5,"avgChangeRate":-0.04935},{"month":6,"riseRate":0.5,"avgChangeRate":0.118659},{"month":7,"riseRate":0,"avgChangeRate":-0.160175},{"month":8,"riseRate":0.2,"avgChangeRate":-0.087422},{"month":9,"riseRate":0,"avgChangeRate":-0.115354},{"month":10,"riseRate":0.6,"avgChangeRate":0.545147},{"month":11,"riseRate":0.2,"avgChangeRate":-0.181708},{"month":12,"riseRate":0.6,"avgChangeRate":-0.012764}],"exchange":"NASDAQ","name":"Acurx Pharmaceuticals, LLC*","nameEN":"Acurx Pharmaceuticals, LLC*"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acurx Pharmaceuticals, LLC*,ACXP,Acurx Pharmaceuticals, LLC*股票,Acurx Pharmaceuticals, LLC*股票老虎,Acurx Pharmaceuticals, LLC*股票老虎国际,Acurx Pharmaceuticals, LLC*行情,Acurx Pharmaceuticals, LLC*股票行情,Acurx Pharmaceuticals, LLC*股价,Acurx Pharmaceuticals, LLC*股市,Acurx Pharmaceuticals, LLC*股票价格,Acurx Pharmaceuticals, LLC*股票交易,Acurx Pharmaceuticals, LLC*股票购买,Acurx Pharmaceuticals, LLC*股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}